Detalhe da pesquisa
1.
Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-Analysis of TWILIGHT and TICO Randomized Trials.
Circulation
; 149(8): 574-584, 2024 02 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37870970
2.
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.
Circulation
; 147(25): 1933-1944, 2023 06 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37335828
3.
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
N Engl J Med
; 385(23): 2150-2160, 2021 12 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34449183
4.
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial.
Am Heart J
; 272: 11-22, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38458371
5.
Prognostic impact of in-stent restenosis in normal weight, overweight, and obese patients undergoing percutaneous coronary intervention.
Catheter Cardiovasc Interv
; 103(2): 260-267, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38173300
6.
Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention.
Catheter Cardiovasc Interv
; 103(3): 425-434, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38314901
7.
Correction: A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease.
PLoS Genet
; 17(4): e1009503, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33822779
8.
Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: Insights from a large PCI registry.
Am Heart J
; 263: 26-34, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37094668
9.
Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
Catheter Cardiovasc Interv
; 101(3): 511-519, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36691863
10.
A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease.
PLoS Genet
; 16(4): e1008629, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32282858
11.
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials.
Eur Heart J
; 43(7): e17-e25, 2022 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31270529
12.
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.
Lancet
; 398(10315): 1974-1983, 2021 11 27.
Artigo
Inglês
| MEDLINE | ID: mdl-34793743
13.
Ticagrelor with or without Aspirin in High-Risk Patients after PCI.
N Engl J Med
; 381(21): 2032-2042, 2019 11 21.
Artigo
Inglês
| MEDLINE | ID: mdl-31556978
14.
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI.
J Thromb Thrombolysis
; 53(2): 380-389, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34386899
15.
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction.
J Thromb Thrombolysis
; 53(1): 20-29, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34347202
16.
Assessment and validation of a novel fast fully automated artificial intelligence left ventricular ejection fraction quantification software.
Echocardiography
; 39(3): 473-482, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35178746
17.
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
Eur Heart J
; 42(45): 4624-4634, 2021 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34662382
18.
Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
Eur Heart J
; 42(45): 4683-4693, 2021 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34423374
19.
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
Circulation
; 141(11): 891-901, 2020 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-31992063
20.
Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGY.
Catheter Cardiovasc Interv
; 97(1): 63-71, 2021 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32406998